Intro
Tesamorelin is a synthetic peptide that stimulates the release of growth hormone from the pituitary gland.
It is approved in some countries to treat HIV-associated lipodystrophy, a condition characterized by abnormal fat accumulation around internal organs.
Researchers are also studying its broader metabolic effects.
Key Points
- Tesamorelin is a growth hormone–releasing hormone analogue.
- It stimulates the body to release growth hormone.
- It is used clinically to reduce visceral abdominal fat in HIV-associated lipodystrophy.
- Research continues into its broader metabolic effects.
Mechanism
Tesamorelin mimics the natural hormone growth hormone–releasing hormone (GHRH).
This triggers the pituitary gland to release growth hormone, which can influence:
- fat metabolism
- muscle mass
- insulin sensitivity
Clinical Evidence
Clinical trials have shown that tesamorelin can reduce visceral abdominal fat in patients with HIV-associated lipodystrophy.
Reducing visceral fat may improve metabolic health in some patients.
Safety Considerations
Possible side effects include:
- injection-site reactions
- swelling
- joint pain
- changes in blood sugar levels
Patients using hormone-related medications should be monitored by medical professionals.
FAQ
Q: What is tesamorelin?
A: Tesamorelin is a peptide that stimulates the release of growth hormone.
Q: What condition is tesamorelin used to treat?
A: It is used to reduce excess visceral fat in people with HIV-associated lipodystrophy.
Q: How does tesamorelin work?
A: It mimics growth hormone–releasing hormone and stimulates the pituitary gland to release growth hormone.
Q: Does tesamorelin cause weight loss?
A: Its approved use relates to fat redistribution rather than general weight loss.
Q: What side effects can occur with tesamorelin?
A: Side effects may include swelling, joint discomfort, or changes in blood sugar levels.
Q: Is tesamorelin used outside HIV treatment?
A: Researchers are studying broader metabolic applications, but approved uses vary.
Q: Why is visceral fat important in metabolic health?
A: High levels of visceral fat are associated with increased risk of metabolic disease and cardiovascular conditions.
Further Reading
Related Guides
- /guides/peptide-therapy